The Supreme Court denied cert in this case; all relevant Supreme Court filings can be found here.
Potential Impact:
Why this Matters:
The Plaintiff argues that the Inflation Reduction Act’s Medicare drug negotiation process violates the Due Process Clause of the Fifth Amendment, Takings Clause of the Fifth Amendment, First Amendment, Eighth Amendment, Unconstitutional Conditions doctrine, and the Administrative Procedure Act. In this appeal, the Plaintiff argues that the district court erred in finding the drug negotiation process lawful.
Potential Impact:
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers, and could severely restrict federal regulatory authority in the health care arena.
Boehringer Ingelheim Pharmaceuticals Inc. v. Department of Health and Human Services et al.
Goal
Issues
Case History
Litigation Content
The Supreme Court denied cert in this case; all relevant Supreme Court filings can be found here.
Potential Impact:
Why this Matters:
The Plaintiff argues that the Inflation Reduction Act’s Medicare drug negotiation process violates the Due Process Clause of the Fifth Amendment, Takings Clause of the Fifth Amendment, First Amendment, Eighth Amendment, Unconstitutional Conditions doctrine, and the Administrative Procedure Act. In this appeal, the Plaintiff argues that the district court erred in finding the drug negotiation process lawful.
Potential Impact:
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers, and could severely restrict federal regulatory authority in the health care arena.
News And Analysis (3)
Health Affairs
IRA Litigation: Pharma’s Failed Challenges To Medicare Drug PricingHealth Affairs
A Tale Of Three Decisions: Courts Continue To Reject Challenges To Medicare NegotiationHealth Affairs
Medicare Drug Price Negotiation Program: A Litigation Status Check33 Major Filings
-
SUPREME COURT NOTICE (May 18, 2026)
-
SUPREME COURT NOTICE (Jan 8, 2026)
-
MANDATE (Oct 3, 2025)
-
JUDGMENT (Aug 7, 2025)
-
PLAINTIFF'S RESPONSE TO NOTICE OF SUPPLEMENTAL AUTHORITY (May 29, 2025)
-
DEFENDANTS' NOTICE OF SUPPLEMENTAL AUTHORITY (May 12, 2025)
-
ORAL ARGUMENT (Apr 3, 2025)
-
PLAINTIFF'S NOTICE (Apr 2, 2025)
-
PLAINTIFF'S REPLY RE: RESPONSE BRIEF (Feb 14, 2025)
-
DEFENDANTS' NOTICE OF SUBSTITUTION OF PARTIES (Feb 14, 2025)
-
AMICUS BRIEF [LAW SCHOLARS] (Jan 28, 2025)
-
AMICUS BRIEF [CENTER FOR AMERICAN PROGRESS ET AL] (Jan 28, 2025)
-
AMICUS BRIEF [MEDICARE EXPERTS] (Jan 28, 2025)
-
AMICUS BRIEF [PATIENTS FOR AFFORDABLE DRUGS] (Jan 27, 2025)
-
AMICUS BRIEF [APHA ET AL] (Jan 24, 2025)
-
AMICUS BRIEF [AARP ET AL] (Jan 24, 2025)
-
AMICUS BRIEF [CONSTITUTIONAL ACCOUNTABILITY CENTER] (Jan 22, 2025)
-
AMICUS BRIEF [PUBLIC CITIZEN] (Jan 22, 2025)
-
DEFENDANTS' RESPONSE BRIEF (Jan 15, 2025)
-
AMICUS BRIEF [FRESENIUS KABI] (Nov 20, 2024)
-
SCHEDULING ORDER (Nov 19, 2024)
-
SCHEDULING NOTICE (Nov 13, 2024)
-
AMICUS BRIEF [ALLIANCE FOR AGING RESEARCH] (Nov 13, 2024)
-
AMICUS BRIEF [CHAMBER OF COMMERCE] (Nov 12, 2024)
-
AMICUS BRIEF {PIONEER PUBLIC INTEREST LAW CENTER] (Nov 12, 2024)
-
AMICUS BRIEF [INSTITUTE FOR FREE SPEECH] (Nov 12, 2024)
-
AMICUS BRIEF [ATLANTIC LEGAL FOUNDATION] (Nov 12, 2024)
-
AMICUS BRIEF [DANIEL E. TROY] (Nov 12, 2024)
-
AMICUS BRIEF [NATIONAL TAXPAYER UNION FOUNDATION] (Nov 12, 2024)
-
AMICUS BRIEF [TEVA] (Nov 11, 2024)
-
AMICUS BRIEF [NEW CIVIL LIBERTIES ALLIANCE] (Nov 8, 2024)
-
AMICUS BRIEF [INDEPENDANT WOMEN'S LAW CENTER] (Nov 8, 2024)
-
PLAINTIFF'S OPENING BRIEF (Nov 4, 2024)
View MoreRelated Litigation
Litigation Information
Current Status
Decision issued
Appeal Filed
Legal Issues
Fifth Amendment - Due Process Cause; Fifth Amendment - Takings Clause; First Amendment - Free Speech Clause; Eighth Amendment - Excessive Fines Clause; Administrative Procedure Act - Notice and Comment Violation
Litigation Metadata
Independent Women’s Law Center; New Civil Liberties Alliance; Atlantic Legal Foundation; Teva Pharmaceuticals USA Inc.; Fresenius Kabi; Institute for Free Speech; Chamber of Commerce; Daniel E. Troy; National Taxpayers Union Foundation; Pioneer Public Interest Law Center
Public Citizen et al.; Constitutional Accountability Center; AARP et al.; APHA et al.; Patients for Affordable Drugs; Law Scholars; Center for American Progress et al.; Medicare Experts